Sign in

CIK 0001099219

  • Large accelerated filer

METLIFE INC

Sign in to watch
Ticker
MET
Exchange
NYSE
Industry
Life Insurance
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
134075851
Phone
+1 212-578-5500
Business address
200 PARK AVENUE, NEW YORK, NY, 10166

Securities

  • MET Common Stock NYSE
  • MET-PA Preferred Series A Floating Rate NYSE
  • MET-PE Depositary Shares NYSE
  • MET-PF Depositary Shares, each representing a 1/1,000th interest in a share of 4.75% Non-Cumulative Preferred Stock, Series F NYSE
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$19,298,702
in 1 filing

Net −$19,298,702. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Khalaf Michel −$19.3M President & CEO sold 20% of stake

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2025-01-02 Harris Carla A Director Grant or award +535 $81.78 $44K 7,336
2025-01-02 MCKENZIE DIANA Director Grant or award +535 $81.78 $44K 20,667
2025-01-02 Kennard William E Director Grant or award +535 $81.78 $44K 41,907
2024-12-16 Johnson Jeh C. Director Grant or award +33 $82.74 $3K 5,069
2024-12-16 Herzog David L Director Grant or award +39 $82.74 $3K 25,340
2024-12-16 Kennard William E Director Grant or award +271 $82.74 $22K 41,372
2024-12-16 Hay Laura J Director Grant or award +13 $82.74 $1K 2,023
2024-12-16 MCKENZIE DIANA Director Grant or award +132 $82.74 $11K 20,132
2024-12-16 GRISE CHERYL W Director Grant or award +536 $82.74 $44K 86,541
2024-12-16 HUBBARD ROBERT GLENN Director Grant or award +579 $82.74 $48K 96,410
2024-12-16 KELLY EDWARD J III Director Grant or award +232 $82.74 $19K 35,523
2024-12-16 Harris Carla A Director Grant or award +16 $82.74 $1K 6,801
2024-12-13 DEBEL MARLENE EVP & Chief Risk Officer Exercise or conversion +13,107 $34.33 $450K 121,614
2024-12-13 DEBEL MARLENE EVP & Chief Risk Officer Exercise or conversion +9,703 $45.91 $445K 131,317
2024-12-13 DEBEL MARLENE EVP & Chief Risk Officer Sale −22,810 $82.88 $1.9M 108,507
2024-12-13 DEBEL MARLENE EVP & Chief Risk Officer Exercise or conversion · Employee Stock Options (right to buy) −13,107 0
2024-12-13 DEBEL MARLENE EVP & Chief Risk Officer Exercise or conversion · Employee Stock Options (right to buy) −9,703 0
2024-12-13 Khalaf Michel President & CEO Exercise or conversion +26,138 $45.91 $1.2M 521,725
2024-12-13 Khalaf Michel President & CEO Sale −20,926 $82.84 $1.7M 500,799
2024-12-13 Khalaf Michel President & CEO Exercise or conversion · Employee Stock Option (Right to Buy) −26,138 0

Page 12 of 13 · 243 trades